Published in Eur J Biochem on September 01, 1999
Cloning, expression, and purification of the K5 capsular polysaccharide lyase (KflA) from coliphage K5A: evidence for two distinct K5 lyase enzymes. J Bacteriol (2000) 1.26
Elongated dermatan sulphate in post-inflammatory healing skin distributes among collagen fibrils separated by enlarged interfibrillar gaps. Biochem J (2001) 0.98
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40
Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem (1978) 4.51
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46
Transient mutism resolving into cerebellar speech after brain stem infarction following a traumatic injury of the vertebral artery in a child. Acta Neurochir (Wien) (1999) 3.37
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A (1992) 2.92
Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol (1997) 2.65
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A (1980) 2.61
The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem (1998) 2.47
Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett (1976) 2.34
Heparan sulfate: a piece of information. FASEB J (1996) 2.33
Biosynthesis of heparin. II. Formation of sulfamino groups. J Biol Chem (1973) 2.27
Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem (1993) 2.23
Retracted A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J (2001) 2.21
A proteoglycan form of heparin and its degradation to single-chain molecules. J Biol Chem (1978) 2.18
Structural organization of the human kininogen gene and a model for its evolution. J Biol Chem (1985) 2.14
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A (1979) 2.08
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1993) 2.07
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem J (1978) 2.03
Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02
Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol (2000) 2.01
Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem (1998) 1.93
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem (2001) 1.89
Heparin-lipoprotein lipase interactions. Fed Proc (1977) 1.87
Domain structure of heparan sulfates from bovine organs. J Biol Chem (1996) 1.84
Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res (1982) 1.83
Mechanism of the anticoagulant action of heparin. Mol Cell Biochem (1982) 1.80
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Control of excitation transfer in photosynthesis. 3. Light-induced decrease of chlorophyll a fluorescence related to photophosphorylation system in spinach chloroplasts. Biochim Biophys Acta (1969) 1.68
Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem (2001) 1.68
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate. Biochem J (1974) 1.59
More to "heparin" than anticoagulation. Thromb Res (1994) 1.57
Glycosaminoglycans and the regulation of blood coagulation. Biochem J (1993) 1.57
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem (1984) 1.56
The chondroitin 4-sulfate-protein linkage. J Biol Chem (1966) 1.55
The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53
Attempted isolation of a heparin proteoglycan from bovine liver capsule. Biochem J (1970) 1.53
Maternal body mass index in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy (2015) 1.53
Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J Biol Chem (1979) 1.53
Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C. J Gastroenterol Hepatol (1999) 1.51
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51
Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J (1984) 1.49
Association of laboratory data and death within one month in cats with chronic renal failure. J Small Anim Pract (2006) 1.49
Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49
Nasotracheal intubation using the Airway Scope and an Endotrol tracheal tube. Anaesthesia (2011) 1.49
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem (1998) 1.47
Antenatal screening for diabetes mellitus. Br J Obstet Gynaecol (1984) 1.47
Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem (1984) 1.46
Identification of N-sulphated disaccharide units in heparin-like polysaccharides. Biochem J (1979) 1.44
Further characterization of the heparin-protein linkage region. Biochim Biophys Acta (1966) 1.44
Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem (1999) 1.42
The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41
Lingual tonsil hypertrophy with difficult airway and uncontrollable bleeding. Anaesthesia (2003) 1.41
A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw (1973) 1.41
Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy (2012) 1.41
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
Biosynthesis of hyaluronic acid by Streptococcus. J Biol Chem (1979) 1.40
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun (2001) 1.39
Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J Biol Chem (1980) 1.38
Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem (1987) 1.38
Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J (1999) 1.38
N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. Anal Biochem (1982) 1.37
Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem (2001) 1.37
Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis. Int J Tuberc Lung Dis (2011) 1.37
Enzymatic assay of serum sialic acid. Clin Chim Acta (1980) 1.37
Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med (1984) 1.36
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36
Fetal heart rate monitoring during labour--too frequent intervention, too little benefit? Lancet (1987) 1.36
Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem (1997) 1.35
Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J (1980) 1.33
Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma. J Biol Chem (1975) 1.32
Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun (1971) 1.32
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem (2000) 1.31
Molecular cloning and expression of a human chondroitin synthase. J Biol Chem (2001) 1.31
Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem (1998) 1.30
Identification of iduronic acid as the major sulfated uronic acid of heparin. J Biol Chem (1971) 1.30
Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J Virol (1998) 1.29
Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol (1979) 1.28
A novel genotyping technique for distinguishing between Flavobacterium psychrophilum isolates virulent and avirulent to ayu, Plecoglossus altivelis altivelis (Temminck & Schlegel). J Fish Dis (2012) 1.28
Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proc Natl Acad Sci U S A (2001) 1.26